Beyond Treatment. We Solve the Puzzle.
A Decade of Scientific Synthesis. Now Transitioning into a Systematic Powerhouse.
Anjaniputra Hospitals was born from a singular obsession: to find the complete answer — not just manage the symptoms — of chronic disease. What began as a one-person crusade to bridge the world's most advanced medical science with Indian patients has evolved into a world-first scientific conglomerate.
Our Mission
To systematically link the global dots of medical science — genomics, neovascularization, bio-regenerative medicine, quantum oncology — into a single, definitive algorithm for chronic disease treatment, accessible to every Indian patient.
Our Vision
To establish 50 state-of-the-art corporate healthcare facilities across every major Indian metropolitan hub, supported by vertically integrated pharmaceutical and biotech manufacturing — making India the world's primary hub for chronic disease answers.
The Anjaniputra Story
Ideated by Prof. Dr. Ravi Tej Allam, Anjani Putra Hospitals was conceived to establish a world-class facility that is protocol-centric and designed for truly personalised, individual-centric treatment. His vision: a medical centre housing the best scientists and doctors in the world, capable of impacting treatment at every layer of human physiology — from the nano scale to the superficial.
The medical centre is unmatched in its technology — advanced enough to address any problem statement with tools that can influence patients at a bio-molecular level, ensuring measurable improvement in the Health Index of the patient rather than mere symptom management.
For decades, Prof. Dr. Ravi Tej Allam spent researching and innovating to develop an Integrated Protocol that impacts all major trouble-shooters of the human body — reinstating the body's inherent, innate, and instinctive infrastructure that signals its own Recovery and Reconstruction Mechanisms.
We are not joining a hospital. We are building an automated system designed to create order out of chaos in the treatment of chronic disease.
Explore the Algorithm →Why the World's Best Hospitals Cannot Solve What We Can
Institutions like the Mayo Clinic represent the gold standard of specialist care — yet they operate with scattered dots. Anjaniputra's algorithm solves this.
The Problem
Global medicine is fragmented. World-class breakthroughs exist in silos — a kidney technology in Israel, a cancer protocol in Switzerland, tissue repair in New Zealand — with no single institution connecting them.
The Algorithm
Anjaniputra is the world's only institution that owns the exclusive rights to each of these dots AND the proprietary recipe to integrate them into one clinical pathway per patient.
The Result
Definitive answers for conditions that have previously only been managed. Even Apollo and KIMS will eventually send their physicians to us for training in these protocols.
A 10-Year Monopoly Across the Entire Value Chain
Our competitive advantage is not infrastructure — it is intellectual property, securing a complete strategic moat across four critical layers.
Treatment
Exclusive rights to execute proprietary algorithm-driven clinical protocols in India. No competitor can legally replicate our procedures.
Distribution
Sole authority to supply our proprietary technology, medical devices and supplements to the Indian market. Our pharmacy products require CEO-level authorization for sale.
Research
The mandate to refine and domesticate global science within Indian incubators — IIT Hyderabad, CCMB, and C-CAMP Bangalore — ensuring regulatory compliance via CDSCO.
Manufacturing
Long-term infrastructure for domestic production of specialized biotech innovations and pharmaceutical assets — eliminating supply chain vulnerability.
What We Stand For
Five values guide every decision — clinical, operational and ethical.
Patient Sovereignty
Every decision begins and ends with what is best for the individual patient — not the system.
Scientific Integrity
We operate only with licensed, evidence-backed, and internationally validated protocols.
Global Collaboration
Seven nations. One algorithm. The world's medical breakthroughs, unified under one roof.
Institutional Transparency
We act honestly with every patient, partner, and regulator — always.
System over Individual
We are building an automated system — not a personality cult — designed to outlast any one clinician.
Innovation
40+ licensed patents and exclusive 10-year technology rights drive our clinical edge.
A Decade of Progress
Key moments in the Anjaniputra journey.
Pre-2020
Scientific Research & Partnership Development
First global technology transfer agreements signed. International advisory network established. 40 patents secured.
2020–2024
Clinical Validation
Protocols validated. Exclusive rights secured with CureSpec (Israel), RGCC (Switzerland), Aroa Biosurgery (New Zealand), European Biomedical Group (Germany), NHS UK, NaviPoint (USA) and SRAM MRAM (UK).
2025
Flagship Facility Development
Hyderabad facility established at Banjara Hills, Road No. 14. CDSCO regulatory engagement initiated. Telangana Government alignment begun.
2026
Inauguration & Franchise Rollout
Inauguration of Hyderabad Model Facility. Franchise rollout commenced. Uganda and African expansion conversations initiated. NHS UK and German delegation visits scheduled.
2026–2030
50 Corporate Facilities
Systematic replication across 50 Indian metropolitan centers. Manufacturing plants operational for pharma and biotech. Full supply chain sovereignty.
Building an Integrated Healthcare Ecosystem
Anjani Putra Hospitals is building far more than a network of advanced medical centres — it is creating an integrated healthcare ecosystem designed to combine scientific innovation, global collaborations, and patient-centric excellence at scale.
Founder & Owner
Prof. Dr. Ravi Tej Allam
Under the visionary leadership of Prof. Dr. Ravi Tej Allam — the founder and owner of Anjani Putra Hospitals — the institution is charting a course that extends well beyond clinical care, into a fully integrated healthcare and manufacturing ecosystem serving India and the world.
National Expansion
Prof. Dr. Ravi Tej Allam's long-term vision is to establish state-of-the-art medical centres across India's major corporate corridors in both Tier 1 and Tier 2 cities — bringing advanced and exclusive healthcare technologies closer to patients and families.
Global Manufacturing Hub
In collaboration with innovation partners from Germany, Switzerland, and New Zealand, Anjani Putra Hospitals aims to bring advanced pharma, biotech, and medical technology manufacturing capabilities to India — positioning the country as a global manufacturing, distribution, and supply hub for transformative healthcare technologies, while driving employment generation, knowledge transfer, and national capability building.
Translating Vision into Execution
Disciplined operational stewardship that turns Prof. Dr. Ravi Tej Allam's growth agenda into a scalable, execution-ready reality.
Saradhi SV
Senior Operations Leader
Saradhi SV brings more than 27 years of experience across operations strategy, integrated operations, supply chain coordination, process excellence, and team leadership — including over 15 years of service in the Indian Navy as an Engineer.
Academic Grounding
Executive MBA from Washington University in St. Louis and IIT Mumbai — providing a rigorous analytical and strategic foundation.
Operational Mandate
Infrastructure readiness, partner integration, quality governance, supply chain continuity, technology transfer, and multi-centre expansion.
Together, visionary medical leadership and disciplined operational stewardship will shape Anjani Putra Hospitals into an institution that is clinically advanced, operationally resilient, and globally aligned.
Whether you are seeking answers for a chronic condition or exploring regenerative medicine — we have a pathway for you.
Our care team is ready to match you with the right specialist and the world's most advanced treatment protocol.